0 items USD 0.00Search
Your search for "delveinsight non hodgkin s lymphoma nhl market insights epidemiology market forecast 2023" gave back 679711 results.
Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Adult Non-Hodgkin Lymphoma Treatment market size is projected to grow from US$ 7434.7 million in 2022 to US$ 13340 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Adult Non-Hodgkin Lymphoma Treatment market size is expected to reach $ 13440 million by 2029, rising at a market growth of 8.0% CAGR...
Catalog:
GIR
August 2023
Price: USD 4,480.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Non-Hodgkin lymphoma (NHL) is an umbrella term for a group of independent diseases with strong heterogeneity The global Adult Non-Hodgkin Lymphoma...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Adult Non-Hodgkin Lymphoma Treatment market size was valued at USD 7820 million in 2022 and is forecast to a readjusted size of USD 13440...
Catalog:
GIR
August 2023
Price: USD 3,480.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Rituxan (Rituximab) and Biosimilar market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Rituxan (Rituximab) Monoclonal Antibody market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL), and one of the subtypes of T-cell lymphoma. The global Anaplastic...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL), and one of the subtypes of T-cell lymphoma. The global Anaplastic...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Market Analysis and Insights: Global Radioimmunotherapy Market The global Radioimmunotherapy market is projected to grow from US$ million in 2023 to...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
